DrugMonitor™ Anti-Racotumomab Antibody (VS-1224-YC972) (CAT#: VS-1224-YC972)
Racotumomab is a form of active immunotherapy designed to stimulate the immune system to recognize and combat cancer cells. It has been used in trials for treating glioma, Wilms' tumor, neuroblastoma, retinoblastoma, and Ewing's sarcoma. The DrugMonitor™ Anti-Racotumomab Antibody (VS-1224-YC972) is an anti-drug antibody (ADA) against Racotumomab. This drug-based antibody is raised in mice immunized with the Racotumomab. The anti-Racotumomab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Racotumomab in samples.
Specific Inquiry
Specifications
- Host Animal
- Mouse
- Specificity
- Racotumomab
- Target
- Racotumomab
- Immunogen
- Racotumomab
- Type
- Mouse IgG
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Racotumomab
- Related Disease
- glioma, Wilms' tumor, neuroblastoma, retinoblastoma, and Ewing's sarcoma
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "racotumomab"
Anti-Human NGcGM3 Recombinant Antibody (Racotumomab)Recombinant Mouse antibody to Human NGcGM3. Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.
Afuco™ Anti-NGCGM3 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H58)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Mouse antibody to Human NGcGM3. It is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-1224-YC972. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: ELISA, IP, FC, FuncS, Neut, IF, WB
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
-1.png)
Application: IB, ELISA, FC, FuncS
-1.png)
Application: WB, ELISA
Application: ELISA, FuncS, IHC, IF, FC, ADCC
Application: ELISA, WB
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
